PALATIN TECHNOLOGIES, INC. Increase Decrease In Operating Lease Liability
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase Decrease In Operating Lease Liability of -$125.84 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$62.13K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$32.38K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$31.34K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$98.44K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for fiscal 2025 was -$380.54K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for fiscal 2024 was -$354.05K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for fiscal 2023 was -$371.12K.
- PALATIN TECHNOLOGIES, INC. increase decrease in operating lease liability for fiscal 2022 was -$351.85K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$62.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$94.50K derived: sum of 2 quarters · filed 2026-05-13 | -$125.84K 10-Q · filed 2026-05-13 | -$224.28K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | -$32.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$63.71K 10-Q · filed 2026-02-17 | -$162.15K derived: sum of 3 quarters · filed 2026-02-17 | -$257.67K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-09-30 | -$31.34K 10-Q · filed 2025-11-14 | -$129.77K derived: sum of 2 quarters · filed 2025-11-14 | -$225.30K derived: sum of 3 quarters · filed 2026-05-13 | -$319.52K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | -$98.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$193.96K derived: sum of 2 quarters · filed 2026-05-13 | -$288.19K derived: sum of 3 quarters · filed 2026-05-13 | -$380.54K 10-K · filed 2025-09-23 |
| 2025-03-31 | -$95.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$189.75K derived: sum of 2 quarters · filed 2026-05-13 | -$282.10K 10-Q · filed 2026-05-13 | -$371.28K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$94.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$186.58K 10-Q · filed 2026-02-17 | -$275.76K derived: sum of 3 quarters · filed 2026-02-17 | -$363.72K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | -$92.36K 10-Q · filed 2025-11-14 | -$181.53K derived: sum of 2 quarters · filed 2025-11-14 | -$269.50K derived: sum of 3 quarters · filed 2025-11-14 | -$356.03K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$89.18K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$177.14K derived: sum of 2 quarters · filed 2025-09-23 | -$263.67K derived: sum of 3 quarters · filed 2025-09-23 | -$354.05K 10-K · filed 2025-09-23 |
| 2024-03-31 | -$87.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$174.49K derived: sum of 2 quarters · filed 2025-05-14 | -$264.88K 10-Q · filed 2025-05-14 | -$357.13K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$86.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$176.91K 10-Q · filed 2025-02-13 | -$269.17K derived: sum of 3 quarters · filed 2025-02-13 | -$363.41K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | -$90.38K 10-Q · filed 2024-11-14 | -$182.64K derived: sum of 2 quarters · filed 2024-11-14 | -$276.88K derived: sum of 3 quarters · filed 2024-11-14 | -$369.82K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$92.26K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$186.49K derived: sum of 2 quarters · filed 2024-09-30 | -$279.44K derived: sum of 3 quarters · filed 2024-09-30 | -$371.12K 10-K · filed 2024-09-30 |
| 2023-03-31 | -$94.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$187.18K derived: sum of 2 quarters · filed 2024-05-15 | -$278.86K 10-Q · filed 2024-05-15 | -$367.48K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$92.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$184.63K 10-Q · filed 2024-02-14 | -$273.25K derived: sum of 3 quarters · filed 2024-02-14 | -$360.65K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | -$91.68K 10-Q · filed 2023-11-14 | -$180.30K derived: sum of 2 quarters · filed 2023-11-14 | -$267.71K derived: sum of 3 quarters · filed 2023-11-14 | -$353.93K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$88.62K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | -$176.03K derived: sum of 2 quarters · filed 2023-09-28 | -$262.24K derived: sum of 3 quarters · filed 2023-09-28 | -$351.85K 10-K · filed 2023-09-28 |
| 2022-03-31 | -$87.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$173.63K derived: sum of 2 quarters · filed 2023-05-15 | -$263.24K 10-Q · filed 2023-05-15 | -$349.85K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$86.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$175.82K 10-Q · filed 2023-02-14 | -$262.44K derived: sum of 3 quarters · filed 2023-02-14 | -$346.94K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$89.61K 10-Q · filed 2022-11-14 | -$176.23K derived: sum of 2 quarters · filed 2022-11-14 | -$260.72K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$86.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | -$171.11K derived: sum of 2 quarters · filed 2022-09-22 | -$316.28K 10-K · filed 2022-09-22 | |
| 2021-03-31 | -$84.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$229.66K 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | -$145.17K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |